ADVERTISEMENT
Why Indian Drugmakers Are Cutting R&D Spends
One area where Pharmaceutical companies are looking at curbing costs is research and development.
11 Dec 2020, 11:36 AM IST
Indian drugmakers cut spending on research and development even prior to the pandemic as they faced pricing pressure and competition in the U.S., their biggest market. The Covid-19 disruption may force them to either further reduce or keep R&D spends in check.Aggregate R&D spend of India's pharmaceutical sector as a percentage of revenue consistently fell in the last three financial years, according to data by Axis Capital. It stood ...
I’m already a Subscriber Sign In
To continue reading this story
Subscribe to unlock & enjoy all Members-only benefits
Choose a plan
Renews automatically. Cancel anytime.
As a Subscriber you get
Full Access to
NDTV Profit App
Exclusives
Premium Stories
Access to
Stories
Curated
Newsletters
20,000+
Research Reports
Priority Pass
to Special Events
Ad-Free
Experience
Members-Only
Rewards
Still Not convinced ? Know More
Get live Stock market updates, Business news, Today’s latest news, Trending stories, and Videos on NDTV Profit.
ADVERTISEMENT